Medicom and the EUDR: a natural commitment to safety, quality, and the environment

At Medicom, safety, quality, and environmental responsibility have always been our top priorities. The European Union Regulation on the prevention of deforestation and forest degradation (EUDR) is a continuation of this commitment and an essential measure for protecting forests and strengthening the sustainability of supply chains.

This regulation will come into force in 2026 and affects several of our product ranges, including dental bibs, care squares, washcloths, cups, and latex gloves. Since its publication, we have fully integrated its requirements, in particular the obligation to make a due diligence declaration via the TRACES platform for all products concerned.

EUDR: a structured traceability approach with our suppliers

To ensure compliance with the EUDR, we have initiated a thorough and structured process with our suppliers of raw materials and finished products. This approach aims to:
 

• collect all data necessary for traceability,

• assess potential risks,

• implement, where necessary, mitigation measures to ensure full compliance.

We remain fully committed to ensuring transparency, compliance, and continuity of supply under this major regulation. Updates will be provided on a regular basis.

EUDR: recent changes voted by the European Parliament

A few weeks ago, we sent you an email newsletter outlining the EUDR requirements and the actions already taken with our suppliers. Since then, the European Parliament has voted on several measures designed to facilitate the implementation of the EUDR. Here are the main changes.

Key changes to note:

1. One-year postponement of the implementation schedule

• Large companies: obligations to be implemented by December 30, 2026

• Micro and small companies: obligations to be implemented by June 30, 2027

2. Simplification of due diligence requirements

• The responsibility for reporting would mainly lie with the company introducing the product to the European market for the first time.

• Simplified procedures are envisaged for small primary operators.

3. Simplified review by April 2026

Cette révision permettra de mieux évaluer les impacts administratifs et les besoins d’ajustement.

Data collection remains complex for EUDR traceability

As is the case across the entire sector, collecting the data required for traceability remains a complex process. This is due to:

• the diversity of raw materials,

• the multitude of stakeholders involved,

• and varying levels of maturity of information systems in supply chains.

This reality requires gradual and meticulous work to ensure the reliability and completeness of the information collected.

In a context where these regulatory adjustments still require official clarification, we believe it is preferable to wait before communicating data on a product-by-product basis, in order to ensure accuracy and compliance with the final framework.

We will get back to you as soon as the simplification of the process has been confirmed and the revised version of the regulation allows for stable and reliable communication.

Medicom remains fully committed to ensuring EUDR compliance

We are actively pursuing all measures to ensure a compliant, controlled, and transparent transition to the EUDR regulation. Our priority remains unchanged: to provide safe, responsible products that comply with European requirements.